COMMUNIQUÉS West-GlobeNewswire

Milestone Scientific Strengthens Board to Support Next Phase of Growth
25/06/2026
Appoints Two Independent Directors with Deep Healthcare, Technology and Financial Expertise Chair of the Board Transitions to Executive Chair to Drive Strategic Execution ROSELAND, N.J., June 25, 2026 (GLOBE NEWSWIRE [...]
Evaluate Recognized for Artificial Intelligence Innovation in 9th Annual AI Breakthrough Awards Program
25/06/2026
Ninth Annual Program Honors the AI Innovators Shaping the Next Era of Global Innovation LONDON, June 25, 2026 (GLOBE NEWSWIRE) -- Evaluate , a Norstella company and the leading global provider of market insights for the [...]
Arrakis Therapeutics Announces CEO Transition with Mark DeLong Appointed as New CEO
25/06/2026
— Mark DeLong to lead Arrakis as it becomes a clinical-stage company, advancing its lead oral RNA-targeted small molecule to treat myotonic dystrophy type 1 (DM1) — — Michael Gilman retires from role of CEO following [...]
Aeroflow Health Acquires Canopie to Close the Maternal Care Gap for Millions of New Mothers
25/06/2026
ASHEVILLE, N.C., June 25, 2026 (GLOBE NEWSWIRE) -- In the ongoing development of its comprehensive maternal health platform, Aeroflow Health , a technology-enabled healthcare company serving millions of patients [...]
Conexeu Sciences Opens Vancouver R&D Facility to Advance Regenerative Tissue Platform
25/06/2026
Nasdaq-Listed Biotech Pioneer Among the First Companies to Operate at adMare's New M4 Innovation Centre RENO, Nev., June 25, 2026 (GLOBE NEWSWIRE) -- Conexeu Sciences Inc. (Nasdaq: CNXU) (“ Conexeu” or the “Company”), a [...]
Medera Announces Independent Data Monitoring Committee (DMC) Recommends Continued Advancement of Lead HFpEF Gene Therapy Program
25/06/2026
Independent DMC recommends continued conduct of the MUSIC-HFpEF study without protocol modification following scheduled review of accumulated clinical data; randomized HFrEF Phase 2 study also reviewed with no safety [...]
DeepView® System Highlighted at the 2026 British Burn Association Annual Conference
25/06/2026
Dr. Jeffrey Carter Awarded BBA Oral Presentation 1st Prize for his Paper on the Use of Multi-Spectral Imaging with Artificial Intelligence for Burn Wounds DALLAS, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral AI, Inc. ( [...]
Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy
25/06/2026
NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within the [...]
Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) Leading Out in Developing Fresh Wave of Inhibitor Classes
25/06/2026
NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands within [...]
Microbot Medical® Wins Surgical Robotics Industry Award for the LIBERTY® Endovascular Robotic System
25/06/2026
Innovative Start-Up award recognizes LIBERTY as a highly innovative, ground-breaking product with potentially wide range and/or substantial benefit HINGHAM, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc [...]
NIMA and RA Capital Launch First-of-Its-Kind Workplace Pilot to Support Employees with Celiac Disease
25/06/2026
New benefit program provides NIMA’s portable gluten sensors at no cost to help employees and their families navigate gluten-free living with greater confidence. BOSTON, June 25, 2026 (GLOBE NEWSWIRE) -- NIMA Partners, [...]
BioRestorative Therapies Announces Completion of BRTX-100 Phase 2 Manufacturing, Highlighting Integrated Regenerative Biologics Platform
25/06/2026
MELVILLE, N.Y., June 25, 2026 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative,” “BRTX,” or the “Company”) (Nasdaq: BRTX ) , a late-stage clinical regenerative medicine company focused on stem cell- [...]
MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer
25/06/2026
Part C domestic enrollment is underway at three clinical sites in the U.S. CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage [...]
Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer
25/06/2026
Appointment supports planned Biologics License Application (BLA) submission in the fourth quarter of 2026 and potential 2027 launch of aglatimagene besadenovec in localized prostate cancer NEEDHAM, Mass., June 25, 2026 [...]
Atalan Launches Nurse Retention Platform Designed to Identify Risk Up to 12 Months in Advance
25/06/2026
Built specifically for nursing, the platform extends Atalan's proven Clinician Retention Intelligence platform to increase retention in healthcare's largest clinical workforce PHILADELPHIA, June 25, 2026 (GLOBE NEWSWIRE [...]
Data Presented on Two-Year Proximal Neck Dynamics from First-in-Human Study of Abdominal Aortic Aneurysm Treatment
25/06/2026
TEMPE, Ariz., June 25, 2026 (GLOBE NEWSWIRE) -- Nectero Therapeutics announced today a first-in-human (FIH) multicenter study evaluated treatment of small- to medium-sized abdominal aortic aneurysms (AAA) with [...]
Provectus Biopharmaceuticals Launches Veripure™, an Open Science Program for Medical Research Access to PV-10 (rose bengal sodium)
25/06/2026
Under Veripure, Provectus is supplying qualified medical researchers with the same pharmaceutical grade rose bengal sodium API used in clinical trials. Veripure is also a quality benchmark, distinguishing program- [...]
Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
25/06/2026
SOUTH SAN FRANCISCO, Calif., June 25, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell [...]
Vaxart Announces Update to BARDA Funding Award to Reflect Current Scope of COVID-19 Oral Pill Vaccine Trial
25/06/2026
Latest Modification is Important Required Step to Releasing 12-month Data from 400-participant Sentinel Cohort Funding to Advance Data Analysis from More Than 5,000 Trial Participants Ahead of Key Trial Results SOUTH [...]

Pages